Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 3/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | RAB9A | P51151 | 2/20 | 0.48 |
| ▸ | NPC1 | O15118 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | HTT | P42858 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14880230 | 0.83 | RAB9A (0.63) | TDP1GAAKMT2AALDH1A1MEN1 | |
| SCHEMBL5261579 | 0.82 | LMNA (0.46) | TDP1LMNAGAAKMT2AALDH1A1 | |
| SCHEMBL3066338 | 0.77 | GAA (0.54) | TDP1LMNAGAAKMT2AALDH1A1 | |
| SCHEMBL8299753 | 0.77 | TDP1 (0.68) | TDP1LMNAGAAKMT2AALDH1A1 | |
| SCHEMBL975125 | 0.76 | SMN1; SMN2 (0.68) | TDP1GAAKMT2AALDH1A1MEN1 | |
| SCHEMBL29777389 | 0.76 | SMN1; SMN2 (0.68) | TDP1GAAKMT2AALDH1A1MEN1 | |
| SCHEMBL29777391 | 0.76 | SMN1; SMN2 (0.68) | TDP1GAAKMT2AALDH1A1MEN1 | |
| SCHEMBL3066298 | 0.75 | TDP1 (0.51) | TDP1LMNAGAAKMT2AALDH1A1 | |
| SCHEMBL3073557 | 0.75 | TDP1 (0.51) | TDP1LMNAGAAKMT2AALDH1A1 | |
| SCHEMBL1367306 | 0.74 | TDP1 (0.65) | TDP1LMNAGAAKMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1699752-B1 | (HETERO)CYCLYL CARBOXANILIDES FOR CONTROLLING HARMFUL FUNGI | BASF AG (DE) | 2007-09-26 | — | — | EP | disclosed |
| US-20070117852-A1 | (Hetero)cyclyl carboxanilides for controlling harmful fungi | BASF AKTIENGESELLSCHAFT (DE) | 2007-05-24 | — | — | US | disclosed |
| EP-1699752-A1 | (HETERO)CYCLYL CARBOXANILIDES FOR CONTROLLING HARMFUL FUNGI | BASF AKTIENGESELLSCHAFT (DE) | 2006-09-13 | — | — | EP | disclosed |
| WO-2005063692-A1 | (HETERO)CYCLYL CARBOXANILIDES FOR CONTROLLING HARMFUL FUNGI | BASF AKTIENGESELLSCHAFT (DE) | 2005-07-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070117852-A1 | (Hetero)cyclyl carboxanilides for controlling harmful fungi | CYCS, CBR3, CYC1 | TDP1 3248/4885LMNA 4093/4885GAA 3325/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.